Fresenius Kabi

Fresenius Kabi specializes in essential and lifesaving medicines alongside technologies for infusion, transfusion, and medical nutrition. The product portfolio comprises a range of highly complex biopharmaceuticals, medical nutrition, medical technologies, and IV generic drugs and solutions.

The products and services are used for the therapy and care of critically and chronically ill patients. Fresenius Kabi is a world market leader in intravenous drugs and parenteral nutrition.  

With more than 41,000 employees and present in over 100 countries, Fresenius Kabi reported more than €8.5 billion revenue in 2025.